Grant Bishop

Tuesday, 10 November 2026 · Markets closed · Edition 20

Elevance

ELV

Elevance Health sells health insurance plans and manages the medical claims and member data behind them. We follow it because it holds data the public web cannot reach, and AI tools can get more out of that data for the company that owns it.

Checked against the company's own business description in its latest annual filing. · entry updated 2026-10-19
Ticker
ELV
Exchange
—
Price
—
Change
—
As of
—
Market cap
—
EV/EBIT
—
P/E NTM
—
FCF yield
—
Net debt/EBITDA
—
Next earnings
—

Last refreshed from 10-Q filed (EDGAR)

Follow · Add to calendar · Daily window

The living report

Bears on our standing view that AI's economy-wide productivity lift does not arrive before 2028. It is proved wrong if productivity jumps much sooner than we expect, or adoption stops spreading.

last revised 19 Oct 2026 · next scheduled disclosure not yet announced
The full report

Members: queues this company for a report on a coming night.

The market record

Free during the preview. Each figure shows only where two independent data providers, Massive and Yahoo, agree on it to the cent; a figure they do not agree on is left out. Dated, not live. It describes; it does not recommend.

Last close$425.62
close of 6 Nov 2026 · Massive and Yahoo agree
The day's range$421.47 – $430.69
6 Nov 2026 · both providers agree
52-week range$274.84 – $450.69
intraday low 9 Mar 2026 · intraday high 21 Oct 2026 · 251 sessions to 6 Nov 2026 · both providers agree
Market value$92.0 billion
the 6 Nov 2026 close × 216,055,891 shares outstanding on the 10-Q cover, as of 15 Oct 2026
$

Enter any price. The page shows the multiple on the forward estimate on file and where that price sits in the 52-week range. It computes; it does not recommend.

Filings

Newest first, from EDGAR. Where a piece read a filing, one line of what it said.

21 Oct 202610-Q · period ending 30 Sep 2026
21 Oct 20268-K · period ending 21 Oct 2026
10 Sep 20268-K · period ending 10 Sep 2026
15 Jul 202610-Q · period ending 30 Jun 2026
15 Jul 20268-K · period ending 15 Jul 2026
10 Jun 20268-K · period ending 10 Jun 2026
13 May 20268-K · period ending 13 May 2026
22 Apr 202610-Q · period ending 31 Mar 2026
22 Apr 20268-K · period ending 22 Apr 2026
10 Mar 20268-K · period ending 10 Mar 2026
2 Mar 20268-K · period ending 2 Mar 2026
26 Feb 20268-K · period ending 26 Feb 2026
6 Feb 202610-K · period ending 31 Dec 2025
28 Jan 20268-K · period ending 28 Jan 2026
10 Dec 20258-K · period ending 10 Dec 2025
10 Nov 20258-K · period ending 10 Nov 2025
21 Oct 20258-K · period ending 21 Oct 2025
21 Oct 202510-Q · period ending 30 Sep 2025
15 Sep 20258-K · period ending 8 Sep 2025
4 Sep 20258-K · period ending 4 Sep 2025
28 Jul 20258-K · period ending 28 Jul 2025
17 Jul 202510-Q · period ending 30 Jun 2025
17 Jul 20258-K · period ending 17 Jul 2025
28 May 20258-K · period ending 28 May 2025
14 May 20258-K · period ending 14 May 2025
22 Apr 202510-Q · period ending 31 Mar 2025
22 Apr 20258-K · period ending 22 Apr 2025
17 Apr 20258-K · period ending 17 Apr 2025
10 Mar 20258-K · period ending 10 Mar 2025
20 Feb 202510-K · period ending 31 Dec 2024
23 Jan 20258-K · period ending 23 Jan 2025

Where it sits in the frame

Reports next

not yet announced

Latest disclosed

10-Q · filed 2026-07-15 · period ending 2026-06-30

Read the filing

Machine-readable

/index/ELV.json

What it has disclosed

Newest first. Every figure traces to a filing; "Show sources" shows which.

—No figure from this company appears in a committed piece yet.

Mentioned in

Every piece that names this company, newest first: what it said, and the standing view it bore on. Written when the piece is committed; never edited, never removed.

—No piece names this company yet.

Same question

Other companies under Who holds data the public web cannot reach?

This entry

19 Oct 2026Entry rewritten in plain words: what the company sells, and why we follow it.
12 Oct 2026Verified against the 10-Q filed 2026-07-15 at launch.

Prices on this page are dated market records, shown free during the preview, each confirmed by two independent data providers. None is a recommendation.

Follow Elevance. The weekly piece, and a note when a filing moves it.

Record

Written according to the Grant Bishop standard — machine-researched, machine-checked, human-judged; then read and committed by the publisher. Every number traces to a filing or a dated market record; every claim carries a date and what would prove it wrong.

Verification
multi-source verified, machine-drafted, human-gated
As of
2026-07-15
Position disclosure
The publisher holds index-level U.S. equity exposure and no direct position in any single name discussed.
Not advice
General commentary for a general audience. Not advice for your situation.
Sources (12)